IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager

IRLAB Therapeutics AB

STO:IRLAB A

Watchlist

Dividends

Price: 13.05 SEK -0.38%

Market Cap: 675.8m SEK

Have any thoughts about
IRLAB Therapeutics AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 13.05 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IRLAB A Alert

IRLAB Therapeutics AB

13.05

-0.05 (-0.38%)

52 Week Range	5.9 19.6
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

IRLAB Therapeutics AB

What unique competitive advantages
does IRLAB Therapeutics AB hold over its rivals?

What risks and challenges
does IRLAB Therapeutics AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of IRLAB Therapeutics AB.

What unique competitive advantages
does IRLAB Therapeutics AB hold over its rivals?

What risks and challenges
does IRLAB Therapeutics AB face in the near future?

Has there been any significant insider trading activity
in IRLAB Therapeutics AB recently?

Summarize the latest earnings call
of IRLAB Therapeutics AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IRLAB Therapeutics AB.

Provide P/S
for IRLAB Therapeutics AB.

Provide P/E
for IRLAB Therapeutics AB.

Provide P/OCF
for IRLAB Therapeutics AB.

Provide P/FCFE
for IRLAB Therapeutics AB.

Provide P/B
for IRLAB Therapeutics AB.

Provide EV/S
for IRLAB Therapeutics AB.

Provide EV/GP
for IRLAB Therapeutics AB.

Provide EV/EBITDA
for IRLAB Therapeutics AB.

Provide EV/EBIT
for IRLAB Therapeutics AB.

Provide EV/OCF
for IRLAB Therapeutics AB.

Provide EV/FCFF
for IRLAB Therapeutics AB.

Provide EV/IC
for IRLAB Therapeutics AB.

Show me price targets
for IRLAB Therapeutics AB made by professional analysts.

What are the Revenue projections
for IRLAB Therapeutics AB?

How accurate were the past Revenue estimates
for IRLAB Therapeutics AB?

What are the Net Income projections
for IRLAB Therapeutics AB?

How accurate were the past Net Income estimates
for IRLAB Therapeutics AB?

What are the EPS projections
for IRLAB Therapeutics AB?

How accurate were the past EPS estimates
for IRLAB Therapeutics AB?

What are the EBIT projections
for IRLAB Therapeutics AB?

How accurate were the past EBIT estimates
for IRLAB Therapeutics AB?

Compare the revenue forecasts
for IRLAB Therapeutics AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of IRLAB Therapeutics AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IRLAB Therapeutics AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of IRLAB Therapeutics AB compared to its peers.

Compare the P/E ratios
of IRLAB Therapeutics AB against its peers.

Discuss the investment returns and shareholder value creation
comparing IRLAB Therapeutics AB with its peers.

Analyze the financial leverage
of IRLAB Therapeutics AB compared to its main competitors.

Show all profitability ratios
for IRLAB Therapeutics AB.

Provide ROE
for IRLAB Therapeutics AB.

Provide ROA
for IRLAB Therapeutics AB.

Provide ROIC
for IRLAB Therapeutics AB.

Provide ROCE
for IRLAB Therapeutics AB.

Provide Gross Margin
for IRLAB Therapeutics AB.

Provide Operating Margin
for IRLAB Therapeutics AB.

Provide Net Margin
for IRLAB Therapeutics AB.

Provide FCF Margin
for IRLAB Therapeutics AB.

Show all solvency ratios
for IRLAB Therapeutics AB.

Provide D/E Ratio
for IRLAB Therapeutics AB.

Provide D/A Ratio
for IRLAB Therapeutics AB.

Provide Interest Coverage Ratio
for IRLAB Therapeutics AB.

Provide Altman Z-Score Ratio
for IRLAB Therapeutics AB.

Provide Quick Ratio
for IRLAB Therapeutics AB.

Provide Current Ratio
for IRLAB Therapeutics AB.

Provide Cash Ratio
for IRLAB Therapeutics AB.

What is the historical Revenue growth
over the last 5 years for IRLAB Therapeutics AB?

What is the historical Net Income growth
over the last 5 years for IRLAB Therapeutics AB?

What is the current Free Cash Flow
of IRLAB Therapeutics AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for IRLAB Therapeutics AB.

Section:

Wall Street
Price Targets

IRLAB A Price Targets Summary
IRLAB Therapeutics AB

There are no price targets for IRLAB A.

IRLAB A Lowest Forecast

Wall Street Target

Not Available

IRLAB A Average Forecast

Wall Street Target

Not Available

IRLAB A Highest Forecast

Wall Street Target

Not Available

Lowest

Price Target

Not Available

Average

Price Target

Not Available

Highest

Price Target

Not Available

IRLAB Therapeutics AB Competitors:
Price Targets

OGI

OrganiGram Holdings Inc

82% Upside

688513

Chengdu Easton Biopharmaceuticals Co Ltd

30% Upside

ELAN

Elanco Animal Health Inc

45% Upside

OFSA3

Ouro Fino Saude Animal Participacoes SA

3% Downside

OGI

OrganiGram Holdings Inc

82% Upside

688513

Chengdu Easton Biopharmaceuticals Co Ltd

30% Upside

ELAN

Elanco Animal Health Inc

45% Upside

OFSA3

Ouro Fino Saude Animal Participacoes SA

3% Downside

ERIS

Eris Lifesciences Ltd

5% Upside

AMIORG

Ami Organics Ltd

2% Upside

ATAI

ATAI Life Sciences NV

322% Upside

LLY

Eli Lilly and Co

29% Upside

Revenue
Forecast

Revenue Estimate
IRLAB Therapeutics AB

For the last 7 years the compound annual growth rate for IRLAB Therapeutics AB's revenue is 69%. The projected CAGR for the next 3 years is 152%.

69%

Past Growth

152%

Estimated Growth

Estimates Accuracy

-1%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
IRLAB Therapeutics AB

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-3%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
IRLAB Therapeutics AB

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-25%

Average Miss

What are analyst estimates?

What is IRLAB A's stock price target?

Not Available

IRLAB A doesn't have any price targets made by Wall Street professionals.

What is IRLAB Therapeutics AB's Revenue forecast?

Projected CAGR
152%

For the last 7 years the compound annual growth rate for IRLAB Therapeutics AB's revenue is 69%. The projected CAGR for the next 3 years is 152%.

IRLAB Therapeutics AB
STO:IRLAB A

Wall Street
Price Targets

IRLAB A Price Targets Summary
IRLAB Therapeutics AB

Revenue
Forecast

Revenue Estimate
IRLAB Therapeutics AB

Operating Income
Forecast

Operating Income Estimate
IRLAB Therapeutics AB

Net Income
Forecast

Net Income Estimate
IRLAB Therapeutics AB

See Also

What is IRLAB A's stock price target?

Not Available

What is IRLAB Therapeutics AB's Revenue forecast?

Projected CAGR
152%

Company

Help

Tools

Stocks

IRLAB Therapeutics AB STO:IRLAB A

Wall Street Price Targets

IRLAB A Price Targets Summary IRLAB Therapeutics AB

Revenue Forecast

Revenue Estimate IRLAB Therapeutics AB

Operating Income Forecast

Operating Income Estimate IRLAB Therapeutics AB

Net Income Forecast

Net Income Estimate IRLAB Therapeutics AB

See Also

What is IRLAB A's stock price target? Not Available

What is IRLAB Therapeutics AB's Revenue forecast? Projected CAGR 152%

Company

Help

Tools

Stocks

IRLAB Therapeutics AB
STO:IRLAB A

Wall Street
Price Targets

IRLAB A Price Targets Summary
IRLAB Therapeutics AB

Revenue
Forecast

Revenue Estimate
IRLAB Therapeutics AB

Operating Income
Forecast

Operating Income Estimate
IRLAB Therapeutics AB

Net Income
Forecast

Net Income Estimate
IRLAB Therapeutics AB

What is IRLAB A's stock price target?

Not Available

What is IRLAB Therapeutics AB's Revenue forecast?

Projected CAGR
152%